Alexion’s mission is to transform the lives of people affected by rare and devastating diseases by developing and delivering valued innovative medicines. In alignment with our mission, we are committed to the Quality of our products, including safely and effectively delivering our transformative medicines to patients and customers in a way that meets the requirements and expectations of all key stakeholders, including global regulatory agencies, local governments and laws. Alexion’s Board of Directors and Executive Committee have established an Executive-level Ethics and Compliance program, led by our Chief Compliance Officer, Compliance Committee and Compliance Team. Alexion’s Compliance program is tailored to meet the standards set forth by the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services in its 2003 Compliance Program Guidance for Pharmaceutical Manufacturers. For more information, please visit https://alexion.com/